Premium
Nocardia farcinica pericarditis after kidney transplantation despite prophylaxis
Author(s) -
McPhee L.,
Stogsdill P.,
Vella J.P.
Publication year - 2009
Publication title -
transplant infectious disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.69
H-Index - 67
eISSN - 1399-3062
pISSN - 1398-2273
DOI - 10.1111/j.1399-3062.2009.00413.x
Subject(s) - medicine , nocardiosis , nocardia , ceftriaxone , amikacin , kidney transplantation , trimethoprim , surgery , sulfamethoxazole , transplantation , antibiotics , microbiology and biotechnology , biology , bacteria , genetics
A deceased‐donor kidney transplant recipient developed purulent pericarditis caused by Nocardia despite trimethoprim–sulfamethoxazole (TMP–SMX) prophylaxis for Pneumocystis jirovecii . She was treated empirically with ceftriaxone and amikacin and subsequently underwent sternotomy with drainage of an intrapericardial abscess. Culture and susceptibility data demonstrated Nocardia farcinica , which was susceptible to SMX and amikacin, although resistant to ceftriaxone. Nocardia asteroides , the more common human pathogen, is generally susceptible to third‐generation cephalosporins and TMP–SMX. N. farcinica is rare in the United States, more virulent and resistant than N. asteroides , and is more likely to cause disseminated disease. Successful therapy of disseminated Nocardia infections is dependent upon choice of appropriate empiric antibiotics in addition to surgical drainage of purulent fluid collections. TMP–SMX prophylaxis may not be sufficient to prevent infections due to Nocardia species in all immunosuppressed transplant recipients. Here, a rare complication of this unusual pathogen is discussed.